含瓦洛蛋白多系统蛋白质病变中的心肌病:评估,诊断和管理
Joshua M Chan1, Candela Romano2, Andy Y Lee1
1Division of Cardiology, Department of Medicine, University of California, Irvine, CA, United States of America.
American heart journal plus : cardiology research and practice
|November 14, 2025
概括
含有瓦洛辛蛋白 (VCP) 的疾病可能会影响心脏,导致心肌病. 早期诊断和向治疗对于管理这种未被充分认识到的疾病至关重要.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
- 神经学 神经学
背景情况:
- 与含瓦洛蛋白 (VCP) 相关的多系统蛋白质病变影响多个器官.
- VCP突变与各种神经和肌肉疾病有关.
- 在VCP疾病中,心脏参与 (心肌病) 往往被忽视.
研究的目的:
- 审查VCP相关心肌病的病理生理学,诊断和管理.
- 建立临床护理和未来研究的框架.
- 突出需要标准化诊断和治疗方法的需要.
主要方法:
- 从动物模型和人类案例研究中审查新出现的证据.
- 对患有VCP变体的患者心声学发现的分析.
- 从心力衰竭指南中推断出当前治疗策略的评估.
主要成果:
- VCP功能障碍破坏心肌细胞平衡,损害蛋白质降解,并改变线粒体功能.
- 患者表现出腹功能障碍,导电异常和心性损伤.
- 目前对于VCP相关心肌病的诊断和管理没有标准化的指导方针.
结论:
- 与VCP相关的心肌病需要进行系统的查和基因型-表型相关性研究.
- 开发有针对性的疗法和生物标志物用于早期检测至关重要.
- 将VCP相关心肌病视为一个独立的实体将改善患者的治疗结果,并指导研究.
相关概念视频
Cardiomyopathy V: Interprofessional Care
323
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
323
Cardiomyopathy III: Hypertrophic Cardiomyopathy
380
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380
Cardiomyopathy VI: Nursing Management
305
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
305
Cardiomyopathy II: Dilated Cardiomyopathy
451
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
451
Cardiomyopathy I: Introduction and Classification
488
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
488
Cardiomyopathy IV: Restrictive Cardiomyopathy
438
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
438


